Pro-Dex, Inc. (PDEX)

In the past six months, Pro-Dex, Inc. announced its fiscal 2026 third-quarter and nine-month results on April 30, 2026, and acquired Advanced Precision Machining on February 12, 2026. The stock price has increased by 7.61% over the past year, trading between $23.47 and $59.22. On May 8, 2026, the stock price surpassed its two-hundred-day moving average, reaching $58.64. The company reported $1.20 earnings per share for the quarter ending April 30, 2026, exceeding estimates, with revenue of $19.95 million. Analysts have given Pro-Dex a "Moderate Buy" rating with an average price target of $56.00.

Based on historical stock price data, there is a suggestion of demand seasonality for Pro-Dex, Inc. products and services. May has shown the highest probability of positive returns at 72.73%, indicating it may be an ideal month to invest in PDEX.

Pro-Dex, Inc. is a medical device manufacturer specializing in powered surgical instruments for OEMs globally, operating within the Healthcare sector. Established in 1978, it offers surgical drivers and shavers for orthopedic, thoracic, and craniomaxillofacial fields, along with engineering, quality, and regulatory consulting services. The company also manufactures rotary air motors and machined sub-assemblies for aerospace and defense systems.

Pro-Dex, Inc. is headquartered in Irvine, California, with manufacturing facilities in Irvine and Tustin. The company has a global market reach, selling its powered surgical instruments to medical device OEMs worldwide.

Pro-Dex has a long-standing history of over 40 years and has collaborated with major providers of medical and dental products. The company emphasizes its credibility through responsiveness and flexibility, and has been recognized as a technology leader in Orange County. There is no information available regarding events that have negatively affected Pro-Dex, Inc.'s brand reputation in the past year.

Major owners of Pro-Dex, Inc. include Nicholas John Swenson, who holds 31.78%. Hedge funds collectively own 37% of shares, with AO Partners Llc being the largest hedge fund shareholder at 28%. Other significant institutional shareholders include BlackRock, Inc., Vanguard Group Inc, and Dimensional Fund Advisors Lp. The company's CEO, Richard Van Kirk, directly holds 3.1% of the total shares outstanding, and individual investors own 34% of the company.